Access to Genetic Testing in Underserved Patients With Cancer
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · May 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how patients with cancer can get information about genetic testing. The study compares two ways of providing this information: one group of patients will receive guidance from a computer-generated character, while another group will get help from a real genetics healthcare provider. Genetic testing can help identify changes in genes that may affect cancer treatment, but many patients face barriers in accessing this important service, especially those from racial and ethnic minority backgrounds or living in rural areas. By using a computer program to educate patients in both English and Spanish, researchers hope to find new ways to improve access to genetic testing.
To join this trial, participants need to be 18 years or older and have been diagnosed with specific types of cancer, such as ovarian cancer, pancreatic cancer, or certain types of breast cancer. They should also be able to read and write in English or Spanish and provide informed consent, meaning they understand what the study involves. Participants can expect to receive valuable information about genetic testing, which may help improve their care. This study is currently recruiting participants, and it aims to make genetic testing more accessible for everyone, particularly those who may not have had the opportunity to learn about it before.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years old
- * Diagnosed with least one of the following:
- • Epithelial ovarian cancer
- • Exocrine pancreatic cancer
- • Metastatic or high or very high-risk prostate cancer
- • Breast cancer at or before age 50
- • Bilateral breast cancer
- • Triple negative breast cancer
- • Male breast cancer OR
- • Healthcare provider who treats patients with any of the above types of cancer
- • Able to read and write in English or Spanish
- • Able to provide informed consent
- Exclusion Criteria:
- • Patients who cannot provide informed consent
- • Patients who cannot see, read, or write
- • Patients who have the cancer and clinical characteristics defined in the inclusion criteria, but who do not speak English or Spanish
- • Patients with none of the listed cancer diagnoses and clinical characteristics
- • Healthcare provider who do not treats cancer patients
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, New York, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Charite Ricker, MS
Principal Investigator
University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported